SCHEMBL10032077

SCHEMBL10032077

Cc1cccc(Cn2c(N3CCCCC3C)nc3c2c(=O)[nH]c(=O)n3C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 1.00
TSHR P16473 6/20 1.00
KMT2A Q03164 5/20 1.00
SMN1; SMN2 Q16637 2/20 1.00
GAA P10253 1/20 1.00
USP2 O75604 1/20 0.60
HPGD P15428 4/20 0.60
MEN1 O00255 4/20 0.58
NPSR1 Q6W5P4 2/20 0.58
MAPK1 P28482 1/20 0.56
TP53 P04637 3/20 0.56
HSD17B10 Q99714 2/20 0.56
HTT P42858 2/20 0.56
ALOX15 P16050 1/20 0.55
KDR P35968 1/20 0.52
DPP4 P27487 1/20 0.52
MAPT P10636 1/20 0.51
POLB P06746 4/20 0.51
SIRT5 Q9NXA8 1/20 0.51
KDM1A O60341 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10032159 0.90 ALDH1A1 (0.81) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL5073403 0.80 DPP4 (0.79) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL4666981 0.73 TSHR (0.72) ALDH1A1TSHRKMT2AGAAMEN1
SCHEMBL4668769 0.71 ALDH1A1 (0.59) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL4668663 0.70 TSHR (0.73) ALDH1A1TSHRKMT2AGAAMEN1
SCHEMBL22800988 0.69 USP2 (0.67) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL13939659 0.69 ALDH1A1 (0.80) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL1068145 0.69 TSHR (0.64) ALDH1A1TSHRKMT2ASMN1; SMN2GAA
SCHEMBL555020 0.68 DPP4 (1.00) ALDH1A1TSHRKMT2AGAAMEN1
SCHEMBL4668968 0.68 ALDH1A1 (0.56) ALDH1A1TSHRKMT2ASMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142682-A1 ANTIVIRULENCE COMPOUNDS INHIBITING BACTERIAL MONO-ADP-RIBOSYLTRANSFERASE TOXINS UNIVERSITY OF GUELPH (CA) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142682-A1 ANTIVIRULENCE COMPOUNDS INHIBITING BACTERIAL MONO-ADP-RIBOSYLTRANSFERASE TOXINS TIPARP, CD38, PARP14 ALDH1A1 4539/4885TSHR 4217/4885KMT2A 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.